A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether it is better to take delavirdine (DLV) plus
indinavir (IDV) plus zidovudine (ZDV) twice a day or three times a day.